
ABUS vs RIGL
$ABUS vs $RIGL head to head: price, market cap, valuation, dividend, free float, relative volume and how actively each trades. The bigger value in the size rows is bolded. Tap either ticker for its live chart, full ownership breakdown and real-time alerts.
ABUS vs RIGL: the quick read
- ·RIGL is the larger company by market cap ($881M vs $880M).
- ·ABUS has been more active on our scanner (113 vs 25 alerts in 30 days).
- ·RIGL has the smaller float (18.7M vs 142.9M), which tends to mean sharper, more volatile moves.
- ·These sit in different industries (PHARMACEUTICAL PREPARATIONS vs Pharmaceutical Preparations), so they answer to different catalysts and a move in one says little about the other.
- ·They trade in different worlds by share price: ABUS is a low-priced stock where a few cents is a real percentage move, while the other is priced for steadier increments.
- ·ABUS draws far more of our scanner's attention, 113 unusual-volume alerts in 30 days against 25, so it is the more actively traded of the two by some distance.
- ·They are closely matched in size, within 0% of each other on market cap, which makes the rest of this table the interesting part.
Objective differences only. Not investment advice.
Get the best catches in your inbox
Free daily email of the top plays and unusual-volume alerts our scanner flags. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Frequently asked questions
Everything you need to know comparing ABUS and RIGL on TheDesperateTrader.
- Is ABUS or RIGL the better stock?
- "Better" depends on your goal, and these two are not alike. RIGL is the larger company by market cap ($881M vs $880M). ABUS has been more active on our scanner (113 vs 25 alerts in 30 days). RIGL has the smaller float (18.7M vs 142.9M), which tends to mean sharper, more volatile moves. Those are the measured differences, not a recommendation, and nothing here is investment advice.
- What is the difference between ABUS and RIGL?
- The differences that matter: they are not in the same business - ABUS is pharmaceutical preparations and RIGL is pharmaceutical preparations; they are similar in size ($880M vs $881M); they trade at very different share prices ($4.58 vs $47.59); ABUS sits at 55% of its 52-week range against 83% for RIGL; our scanner flagged ABUS 113 times in the last 30 days against 25 for RIGL. Everything above is measured from the latest completed session and SEC filings.
- Which of ABUS and RIGL is more active right now?
- Right now ABUS is at about 1.2x its normal volume and RIGL is at about 0.7x, so ABUS is the one drawing unusual attention today. Relative volume (RVOL) compares a stock's volume to its own recent average, so it reads the same way for a megacap and a microcap and is the quickest way to tell which of two similar names is actually in play.
- Is this comparison data live?
- Prices and % changes are anchored to the latest completed session and split-adjusted, so a reverse split never shows as a fake move. Float is estimated from SEC filings and refreshed as new filings publish.
Trading ABUS or RIGL? Get real-time unusual-volume alerts the moment either one moves, free.
No card · 5 premium daysMore ABUS and RIGL comparisons
Same sector, similar size. These are the peers each one is usually weighed against.
Explore the market
Free, live market tools. No account required to look.